Phibro Animal Health | PAHC - Loan Capital


Phibro Animal Health reported $603.6M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Align Technology USD 0 0 Dec/2024
ANI Pharmaceuticals USD 291.84M 5.84M Dec/2025
Assertio Holdings USD 39.17M 120K Sep/2025
Aurora Cannabis CAD 33.2M 1.79M Dec/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Canopy Growth CAD 224.99M 1.34M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Henry Schein USD 2.31B 157M Dec/2025
Idexx Laboratories USD 374.84M 17K Dec/2025
Knight Therapeutics CAD 57.78M 26.92M Dec/2025
Merck USD 39.97B 6B Sep/2025
Nektar Therapeutics USD 107.51M 10.35M Jun/2024
Pacira USD 372.19M 4.53M Dec/2025
Phibro Animal Health USD 603.6M 5.92M Dec/2025
Prestige Brands USD 1.05B 39.73M Dec/2025
Supernus Pharmaceuticals USD 400.38M 21.13M Mar/2022
Zoetis USD 9.04B 1.97B Dec/2025